HIV Malignancy Specimens for Research at No Charge
The purpose of this Notice is to encourage current funded NCI extramural investigators to apply for administrative supplements to support mentored cancer research career development of early-stage low- and middle-income …
The American Association for Cancer Research (AACR)-Genmab Non-Hodgkin B-cell Lymphoma Research Fellowship provides a two-year grant of $120,000 to support the salary and benefits of a postdoctoral or clinical research …
The ACSR is pleased to share the following NIH/NCI funding opportunities. 1. Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Stimulate Research in HIV/AIDS Cancer Research Projects at …
NOT-CA-22-031 Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) The purpose of this announcement …
RFA-CA-22-001, U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) has been published. This is a reissuance of RFA-CA-20-001. The purpose of this Funding Opportunity Announcement …
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trials Not Allowed) Attention Biorepositories and Biospecimen Science Programs! The earliest submission date for this National Cancer Institute Funding Opportunity …
The U.S. National Cancer Institute (NCI)-funded AIDS and Cancer Specimen Resource (ACSR) is pleased to announce the release of the Young Investigator Pilot Award (YIPA) for Fall 2021. We welcome …
The purpose of this National Institutes of Health Funding Opportunity Announcement (FOA) is to support Implementation Science for Cancer Control in People Living with HIV (PLWH) in Low- and Middle-Income …
These National Institutes of Health (NIH) Funding Opportunity Announcements (FOA) solicit research to better understand the epidemiology & biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in …
